Gradient DDD/1,000 patient-days vs. time before HCAASb
Gradient DDD/1,000 patient-days vs. time after HCAASb
P valuea
Restricted antimicrobials
Amikacin
−0.1433
−0.1137
<0.001
3rd and 4th Cephalosporins
1.4668
0.8632
<0.001
Fluoroquinolones
0.2937
0.0567
<0.001
Carbapenems
-0.1450
0.3904
<0.001
Glucopeptides
0.2780
0.1794
<0.001
Non-restricted antimicrobials
Ampicillin
−0.2052
−0.0979
<0.001
Amoxicillin+Clavulanic acid
0.0523
0.1823
<0.001
Oxacillin
0.3901
−0.4200
<0.001
Gentamicin
−0.4647
−0.3444
<0.001
Cefuroxime
−0.1923
−0.1652
<0.001
Cefazolin
−0.4144
0.1129
0.049
實施審核系統前後
抗生素耗用量差異統計分析
§YY Chan; TY Lin; CT Huang; ST Deng; TL Wu;
§HS Leu; CH Chiu, IJAA 38 (2011) 486– 492